Hurley Capital »

Crispr Therapeutics Ag call shares owned by Hurley Capital

Quarter-by-quarter ownership of Crispr Therapeutics Ag call shares owned by Hurley Capital from 13F filings

Historical chart of Hurley Capital investment in Crispr Therapeutics Ag call

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics Ag call held by Hurley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics Ag call by Hurley Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.1k 25 325.00

More positions owned by Hurley Capital

Vanguard Index Fds Vanguard Value Etf Formerly Vanguard Index Tr Value Etf (VTV)
Ishares Ibonds 2026 Termhigh Yield Uit Exchange Traded (IBHF)
Vanguard Russell 1000 Growth Etf Uit Exchange Traded (VONG)
Enterprise Prods Part Limited Partnershp (EPD)
Vanguard Index Funds S&p 500 Etf Usd S&p 500 Etf Shs (VOO)
Vanguard Inter-term Treas Index Uit Exchange Traded (VGIT)
Sprott Physical Silver E Closed End Mutl Fund (PSLV)
Schwab International Equity Etf Uit Exchange Traded (SCHF)
Alphabet Inc Class Class A Common Stock (GOOGL)
Ishares Tr Ibonds 2027 Term Ibonds 2027 Term (IBHG)
Select Sector Spdr Trust Technology Select Sector Usd Dis Technology (XLK)
Morgan Stanley Common Stock (MS)
Schwab Strategic Tr Us Large-cap Etf Us Lrg Cap Etf (SCHX)
Spdr S&p 500 Etf Uit Exchange Traded (SPY)
Schwab Us Large Cap Growth Etf Uit Exchange Traded (SCHG)

View all positions for Hurley Capital

Top funds holding Crispr Therapeutics Ag call

IMC-Chicago
Group One Trading
Simplex Trading
Maven Securities
National Bank Of Canada /fi/
Hurley Capital
Advisor Group Holdings

View all funds holding Crispr Therapeutics Ag call